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Abstract: 
Cyclo-oxygenase 2 (COX2) inhibiting drugs were subjected to comparative quantitative structure activity relationship 
(QSAR) analysis with an attempt to derive and to understand the relationship between the biological activity and molecular 
descriptors by multiple regression analysis. The different drugs that inhibit cyclo-oxygenase 2 enzyme were compared 
instead of subjecting one drug and its derivatives to QSAR analysis. The study was conducted to look for the common 
structural features between the drugs which confer to a good biological activity. Based on the regression analysis the 
following descriptors were finalized as the components fitting best in the regression equations: Ss, SCBO, RBN, nN, SIC0, 
IC1, and H-055. These descriptors belong to constitution (Ss, SCBO, RBN, nN), information indices (SIC0, IC1) and atom 
centered fragments (H-055) category. Based on these descriptors QSAR models were generated and evaluated for best 
structure-activity correlation. The model generated from constitution and information indices descriptors corresponds to the 
essential structural features of the drugs and are found to have significant correlation with COX2 inhibiting activity. This 
study shall help in rational drug design and synthesis of new selective cyclo-oxygenase 2 inhibitors with predetermined 
affinity and activity. 
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Background: 
Quantitative structure –activity relationship (QSAR), is a 
type of analysis where some measures of chemical 
properties are correlated with biological activity to derive a 
mathematical illustration of the underlying structure 
activity relationship (SAR) [1]. Descriptors are numerical 
representations of specific molecular features. Such features 
can range from very simple ones such as the number of 
carbons to more complex and abstract features such as 
graph invariants of the molecular graph. Quantitative 
structure–activity relationship (QSAR) studies are 
unquestionably of great importance in modern chemistry 
and biochemistry. To get an insight into the structure-
activity relationship we need molecular descriptors that can 
effectively characterize molecular size, molecular branching 
or the variations in molecular shapes, and can influence the 
structure and its activities [2, 3]. A number of prospective 
studies show that COX enzyme gets increased in inflamed 
tissue and that COX is stimulated by interleukin-1 (IL-1) [4]. 
Cyclo-oxygenase (COX) converts arachidonic acid derived 
from cell membranes to prostaglandins, which have 
important signaling and housekeeping functions, 
particularly in platelets, the gastrointestinal tract, lungs, and 
kidneys. The two COX isoforms are the constitutive form 
(COX1) and the inducible form (COX2). Pharmacological 
inhibition of COX2 can provide relief from the symptoms of 
inflammation and pain [5]. COX2 inhibitors are a new class 
of non-steroidal anti-inflammatory drugs (NSAIDs). 
Because they selectively block the COX2 enzyme, blocking 
this enzyme obstructs the production of the chemical BIOINFORMATION  open access 
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messengers (prostaglandins) that cause the pain and 
swelling of arthritis inflammation. The COX2 inhibitor 
flurbiprofen is shown at its active site with COX2 (Figure 1). 
Selectivity for COX2 provides the anti-inflammatory action 
and also reduces the risk of peptic ulceration. COX2 
inhibitors have recently been implicated in cancer 
prevention and the slowing of atherosclerosis [6, 7]. Dataset 
containing 15 COX 2 inhibiting drugs were formed and 
subjected to descriptor determination. At first a variety of 
molecular descriptors were calculated and 7 were finalized 
by multiple linear regression. The selected 7 molecular 
descriptors were found to confer the known biological 
activities of 15 COX2 inhibitors. Moreover, a regression 
model was hypothesized based on the results, which would 
be helpful for structural optimization of COX2 inhibitors. 
 
 
Figure 1:  (a) Cyclo-oxygenase 2 complexes with inhibitor 
flurbiprofen. Selective inhibition of cyclo-oxygenase 2 
enzyme by the inhibitor flurbiprofen [PDB: 3pgh]. The 
cyclo-oxygenase 2 enzyme is shown as cartoon and the 
inhibitor as the stick model in green color at its active site. 
(b)  Interaction between the cyclo-oxygenase and 
flurbiprofen. Black dashed line – hydrogen bonds, salt 
bridges and metal interactions; green solid lines- 
hydrophobic interactions. (Image generated using PoseView 
software) 
 
Figure 2: The drug dataset (15 drugs) taken for the study. 
The structures of the drugs were taken from Pubchem and 
drug bank databases. The structures were then drawn and 
optimized using ACD labs 3D optimizer. 
 
One of the first ever a QSAR model is that of Richardson 
(1869) where the narcotic effect of a series of alcohols was 
correlated with molecular weight. [8]. Bazoui and colleagues 
(2002) derived QSAR for 103 analogues of 1-(2-
hydroxyethoxy) methyl-6-(phenylthio) thymine (HEPT), a 
potent inhibitor of the HIV-1 reverse transcriptase, by means 
of multiple linear regression (MLR) and artificial neural 
network (ANN) techniques. The results showed that the 
anti-HIV activity of HEPT derivatives was strongly 
dependent on hydrophobic character and also steric factors 
of substituent [9]. Guha and Jurs (2004) developed 
Quantitative Structure−Activity Relationship (QSAR) 
models to predict the biological activity of 179 artemisinin 
analogues. Multiple linear regression and computational 
neural network models are developed to link the structures 
to their reported biological activity [10]. Jain and Agrawal 
(2006) applied step-wise multiple regression analysis and 
reported lipophilicity and topological distance indices are 
important for COX2 inhibition [11]. Khan and colleagues 
(2006) studied quantitative structure activity relationship 
analysis on a series of N-alkyl imidazole analogues using 
combination of various thermodynamic electronic and 
spatial descriptors. The study revealed that the electronic 
property, i.e., dipole moment contributed positively, and 
spatial descriptor (principal moment of inertia at Y axis) 
contributed negatively to the biological activity [12]. Livia 
and colleagues (2007) conducted comparative molecular BIOINFORMATION  open access 
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field analyses (CoMFA) on a large set of estrogen receptor 
(ER) modulators. Results indicate that steric, electrostatic, 
hydrophobic (lipophilic) and hydrogen bond donor 
substituents play a significant role in COX2 inhibitory 
activity and selectivity of the compounds [13]. 
 
Methodology: 
Molecular structure and optimization 
The COX2 inhibiting drugs were collected from several 
public sources like drug bank and from literature (Figure 2) 
[14]. The structures of the drugs were obtained from 
PubChem. ACD-Chemsketch was used to draw the 
inhibitors (drugs) structure. The structures were then 
optimized using 3D optimizer of ACD Labs Software 
(Figure 2) and the structures were saved in the pdb format.  
 
 
Figure 3: (a) The graph plotted between predicted and 
observed biological activity (r= 0.933). The predicted activity 
shows linear relationship with observed activity because fit 
of the data to the regression line is good. (b)  The graph 
plotted between observed and the residual biological 
activity.  (c) Graph plotted between predicted and the 
residual biological activity. 
 
The biological activity 
The biological activity of the drugs i.e the IC50 values, were 
obtained from the Pubchem database Table 1 (see 
supplementary material). IC50 values were retrieved based 
on its selective inhibition of cyclo-oxygenase 2 enzymes in 
human. 
 
QSAR descriptors 
The optimized structures of the 15 drugs have been used for 
calculating molecular descriptors using E-Dragon [15]. The 
descriptor types chosen were constitutional descriptors, 
information indices, functional group counts, topological 
descriptors, atom centered fragments and molecular 
properties. This analysis resulted with 142 individual 
descriptor values. This total descriptor values were 
shortlisted by regression analysis. The normalized values 
have then been used to generate QSAR models by the means 
of multiple linear regression analysis. The QSAR model was 
generated using Build QSAR module [16]. 
 
Discussion: 
Multiple regression analysis 
Each of the 15 drugs was analyzed for the molecular 
descriptors using E-dragon and the results were recorded. 
MLR is a method used for modeling linear relationship 
between a dependent variable Y (IC50) and independent 
variable X (2D descriptors). Out of 142 descriptors for the 
series of 15 COX2 inhibitors, 7 were found to be significant 
by multiple regression analysis using the SPSS statistical 
package Table 2 (see supplementary material).  
 
Set of Final Descriptors  
All the suitable descriptors were analyzed and finally the 
seven descriptors were found to suite the fifteen COX2 
inhibitors. The E-Dragon software was used to calculate the 
descriptors for each molecule. The 7 Descriptors found 
significant were Ss, SCBO, RBN, nN, SIC0, IC1, and H-055 
Table 2 (see supplementary material). The QSAR analysis 
was done using the Build QSAR module. These descriptors 
belong to constitution, information indices and atom 
centered fragments category. These values were used for 
further calculation and model generation. The graph has 
been plotted between the experimental and the predicted 
IC50 values.  
 
QSAR Model Generation 
Using the above-mentioned 7 descriptors the QSAR models 
were generated using Build QSAR model generator. The 
predicted activity value is the predicted IC50 value 
generated by the Build QSAR module, residual activity is 
the difference between the observed and predicted IC50 
values. When the drug bioactivity data and descriptor data 
which fall under constitution, information indices and atom 
centered fragments category were subjected to multiple 
regression analysis the following significant equations were 
obtained.  
 
n=015; r=0.966; r²(R) = 0.933; s=2.314; F=18.711 – Model 1 
 
This equation is obtained by analyzing the constitution (Ss, 
SCBO, RBN, nN) and information indices (SIC0, IC1) 
descriptors, where n is number of molecules under analysis, 
r is the correlation coefficient, r²(R) is the squared correlation 
coefficient, s is the standard deviation, F is the F statistical 
value. The cross validated squared correlation coefficient, 
Q2 is 0.495 and standard deviation of sum of square of BIOINFORMATION  open access 
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difference between predicted and observed values, SPRESS 
is 6.377. 
 
n=015; r=0.650; r²(R) = 0.423 s=6.427; F=1.319 – Model 2 
This equation is obtained by analyzing the constitution (Ss, 
SCBO, RBN, nN) and atom centered fragments (H-055) 
descriptors with Q2=1.354 and SPRESS=12.979 
 
n=015; r=0.953; r²(R) =0.908 s=2.317; F=36.332 – Model 3 
 
This equation is obtained by analyzing the information 
indices (SIC0, IC1) and atom centered fragments (H-055) 
descriptors with Q2=0.661 and SPRESS=4.454 
 
 
Figure 4: Steps followed for QSAR analysis for cox2 
inhibitors. Dataset contains a total of 15 cyclo-oxygenase2 
inhibiting drugs. Totally seven descriptors were subjected to 
QSAR model generation and validation.  
 
Evaluating the model 
Among the above three models, model 1 has produced high 
statistical quality equation (n=015; r=0.966; r²(R) = 0.933; 
s=2.314; F=18.711) which was obtained by pooling 
constitution (Ss, SCBO, RBN, nN) and information indices 
(SIC0, IC1) descriptors. It is seen that model 1 has highest r 
and R value i.e. 0.966 and 0.933 respectively and lowest 
standard deviation(s = 2.314) when compared to other two 
models. The Q2 value is low than the other two, however, 
based on the correlation coefficient and the standard 
deviation model 1 can be considered as the best one among 
the generated models. It is seen that the average observed 
activity in model 1 is 2.876; average predicted activity is 
3.123467; and the residual activity value does not deviate 
beyond ±1 and its average being 0.248 Table 3 (see 
supplementary material). Hence the chosen descriptors best 
fit for the COX2 inhibition. The auto correlation between the 
descriptors studied was analyzed Table 4 (see 
supplementary material). The highest correlation is 
observed between the descriptors RBN and SIC0 with the 
value 0.277. 
 
Graphical Analysis 
The graphical analysis has been performed and the graph is 
shown in (Figure 3). The graph has been plotted between 
the predicted and observed IC50 values (Figure 3a). The 
predicted activity shows linear relationship with observed 
activity because fit of the data to the regression line is good. 
The higher the value for r2, less likely the relationship is due 
to chance. This QSAR investigation indicates that the 
descriptors namely Ss, SCBO, RBN, nN SIC0, IC1 for the set 
of cyclo-oxygenase inhibitors studied were found to have a 
great deal to positively contribute to biological activity. The 
graph is plotted for observed activity versus residual 
(Figure 3b) and predicted activity versus residual (Figure 
3c). The finalized descriptors were found to be the members 
of constitutional and information indices. The workflow for 
the present comparative QSAR study is shown in (Figure 4). 
Thus, this work sets sights on to identify the associated 
molecular properties of COX2 inhibiting drugs and exploit it 
to optimize COX2 inhibiting activity. 
 
Conclusion: 
COX2 plays a significant role in the development of various 
symptoms and conditions, including fever, inflammation, 
and pain. The overall result of the conducted comparative 
QSAR analysis explicates the exploration of common 
structural descriptors of the COX2 inhibiting drugs in 
explaining its bioactivity against the cyclo-oxgenase 
enzyme. These descriptors indicate simple structural 
features like constitution property, information indices and 
atom centered fragments which confer to better bioactivity. 
This provides insight into the physicochemical nature of the 
activity under consideration. The results of this study might 
pave the way towards rationalizing the design and 
discovery of novel COX2 inhibitor.   
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Supplementary material: 
 
Table 1: Drugs and their IC50 values.  
Sl.No Drug  IC50  µM 
1 Aspirin  0.30 
2 Diclofenac  0.01 
3 Diflunisal  2.70 
4 Etodolac  2.00 
5 Flurbiprofen  0.01 
6 Ibuprofen  0.10 
7 Ketorolac  0.23 
8 Meloxicam  0.70 
9 Mephenamic  acid  1.33 
10 Naproxen  0.06 
11 Paracetamol  25.58 
12 Phenylbutazone  10.00 
13 Rofecoxib  0.02 
14 Tolmetin  0.09 
15 Valdecoxib  0.01 
The IC50 were retrieved from the PubChem database. This activity is selective to cyclo-oxygenase 2 enzyme in human cells. 
 
Table 2: Final Descriptors selected by MLR. Ha - The superscript represents the formal oxidation number. The formal oxidation number of a carbon 
atom equals the sum of the conventional bond orders with electronegative atoms; the C--N bond order in pyridine may be considered as 2 while we 
have one such bond and 1.5 when we have two such bonds; the C..X bond order in pyrrole or furan may be considered as 1. 
S.No  Name  Description  Type of Descriptors 
1  Ss  Sum of  Kier – Hall electropological states  Constitutional 
2  SCBO  Sum of conventional bond orders  Constitutional 
3  RBN  Number of rotatable bonds  Constitutional 
4  nN  Number of nitrogen atoms  Constitutional 
5  SIC0  Structural Information Content (Neighborhood Symmetry Of 0-Order)  Information indices 
6  IC1  Information Content Index (Neighborhood Symmetry Of 1-Order)  Information indices 
7 H-055  Ha attached to C0(sp3) with 4X attached to next C  Atom Centered Fragments 
 
Table 3: The observed and the predicted biological activity of the drugs.  
Compounds  Observed activity  Predicted activity  Residual 
Aspirin 0.300  0.26  0.040 
Diclofenac 0.005  1.305  -1.300 
Diflunisal 2.700  0.59  2.110 
Etodolac 2.000  0.128  1.872 
Flurbiprofen 0.010  1.791  -1.781 
Ibuprofen 0.100  1.756  -1.656 
Ketorolac 0.230  1.002  -0.772 
Meloxicam 0.700  0.528  0.172 
Mephenamic acid  1.330  1.081  0.249 
Naproxen 0.060  1.836  -1.776 
Paracetamol 25.580  25.607  -0.027 
Phenylbutazone 10.000  6.6  3.400 
Rofecoxib 0.020  3.293  -3.273 
Tolmetin 0.090  0.901  -0.811 
Valdecoxib 0.010  0.174  -0.164 
Average 2.876  3.124  -0.248 
The average observed, predicted and residual activity being 2.876, 3.124 and-0.248 respectively. 
 
Table 4: The auto correlation matrix between the descriptor values  
 Ss  SCBO  RBN  nN  SIC0  IC1 
Ss  1  0.264  0.128 0.171 0.003 0.087 
SCBO   1  0.033 0.031 0.014 0 
RBN      1  0.002 0.277 0.188 
nN       1  0.013  0.09 
SIC0        1  0.638 
IC1         1 
The highest correlation is observed between the descriptors RBN (number of rotatable bonds) and SIC0 (structural information content). 
 
 